STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[SCHEDULE 13D/A] Gabelli Healthcare & WellnessRx Trust SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D/A
Rhea-AI Filing Summary

Gabelli-affiliated filers amended their Schedule 13D on Gabelli Healthcare & WellnessRx Trust’s preferred shares, disclosing an aggregate beneficial ownership of 3,314,000 shares, or 61.05% of the 5,428,514 shares outstanding as reported by the issuer.

The group reported using approximately $18,322,400 to purchase additional Series G cumulative preferred shares in a private placement. Within the aggregate, Associated Capital Group, Inc. holds 2,200,000 shares (40.53%), GAMCO Investors, Inc. holds 400,000 (7.37%), Mario J. Gabelli holds 400,000 (7.37%), and the Gabelli Foundation, Inc. holds 314,000 (5.78%). A disclosed transaction shows 1,800,000 Series G shares purchased at $10.1791 on 10/30/2025 in a private placement.

Positive
  • None.
Negative
  • None.

Insights

Filers report 61.05% of GRX preferred after a private placement buy.

The amendment lists aggregated control of 61.05% of Gabelli Healthcare & WellnessRx Trust preferred shares, tied to 3,314,000 shares versus 5,428,514 outstanding as reported by the issuer. It details roles across affiliated entities and assigns sole voting and dispositive power to the respective holders, with fund-level proxy committees noted for specific circumstances.

A disclosed private placement on 10/30/2025 shows 1,800,000 Series G shares purchased at $10.1791, with aggregate recent purchases of approximately $18,322,400. Cash-flow direction is from the reporting persons (including client funds at AC) into the securities, consistent with a position increase.

Actual impact depends on the preferred class’s rights and the holders’ decisions. Subsequent filings may provide further details on any changes in intentions or additional transactions.






If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D


GAMCO INVESTORS, INC. ET AL
Signature:PETER D. GOLDSTEIN
Name/Title:GENERAL COUNSEL
Date:10/30/2025
GABELLI FOUNDATION, INC.
Signature:DAVID GOLDMAN
Name/Title:ATTORNEY-IN-FACT
Date:10/30/2025
GGCP, INC.
Signature:DAVID GOLDMAN
Name/Title:ATTORNEY-IN-FACT
Date:10/30/2025
Associated Capital Group, Inc.
Signature:PETER D. GOLDSTEIN
Name/Title:CHIEF LEGAL OFFICER
Date:10/30/2025
GABELLI MARIO J
Signature:DAVID GOLDMAN
Name/Title:ATTORNEY-IN-FACT
Date:10/30/2025

FAQ

What ownership did the Gabelli group report in GRX preferred?

They reported 3,314,000 shares, representing 61.05% of 5,428,514 shares outstanding as reported by the issuer.

How much did the filers spend recently on GRX preferred?

They used approximately $18,322,400 to purchase additional Series G cumulative preferred shares in a private placement.

Which entity holds the largest portion of GRX preferred?

Associated Capital Group, Inc. holds 2,200,000 shares, or 40.53% of the class.

Were there recent transactions disclosed for GRX preferred?

Yes. On 10/30/2025, 1,800,000 Series G shares were purchased at $10.1791 in a private placement.

What are other notable holdings by the filers in GRX preferred?

GAMCO Investors, Inc. 400,000 (7.37%), Mario J. Gabelli 400,000 (7.37%), and Gabelli Foundation, Inc. 314,000 (5.78%).

Do the filers have voting and dispositive power over the shares?

Each reporting person has sole voting and sole dispositive power over its reported shares, with fund proxy committees applicable in certain cases.
Gabelli Health & Wellness

NYSE:GRX

GRX Rankings

GRX Latest News

GRX Latest SEC Filings

GRX Stock Data

143.66M
15.50M
1.83%
37.13%
0.02%
Asset Management
Financial Services
Link
United States
Rye